Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericytes | 10 | 2024 | 293 | 3.770 |
Why?
|
Hypertension, Pulmonary | 17 | 2024 | 1570 | 3.060 |
Why?
|
Endothelial Cells | 15 | 2024 | 3539 | 1.200 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2024 | 686 | 0.810 |
Why?
|
Pulmonary Artery | 7 | 2021 | 1921 | 0.730 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 454 | 0.610 |
Why?
|
Neovascularization, Pathologic | 4 | 2019 | 2640 | 0.590 |
Why?
|
Lung | 10 | 2024 | 9994 | 0.590 |
Why?
|
Education, Graduate | 1 | 2016 | 75 | 0.520 |
Why?
|
Cell Polarity | 2 | 2019 | 638 | 0.510 |
Why?
|
Writing | 1 | 2016 | 199 | 0.470 |
Why?
|
Cell Movement | 6 | 2019 | 5206 | 0.410 |
Why?
|
Wnt Proteins | 2 | 2016 | 719 | 0.380 |
Why?
|
Lung Diseases | 1 | 2021 | 1915 | 0.370 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1392 | 0.340 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1617 | 0.310 |
Why?
|
MicroRNAs | 3 | 2013 | 3790 | 0.300 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1116 | 0.290 |
Why?
|
Hepatitis B | 1 | 2012 | 701 | 0.270 |
Why?
|
Animals | 29 | 2024 | 167963 | 0.270 |
Why?
|
Mice | 19 | 2024 | 81208 | 0.250 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2016 | 1485 | 0.250 |
Why?
|
Pipecolic Acids | 1 | 2023 | 78 | 0.220 |
Why?
|
Neurogenic Inflammation | 1 | 2023 | 33 | 0.220 |
Why?
|
Coculture Techniques | 2 | 2019 | 1342 | 0.210 |
Why?
|
beta Catenin | 4 | 2016 | 1043 | 0.200 |
Why?
|
Neurons, Afferent | 1 | 2023 | 498 | 0.190 |
Why?
|
Antithrombins | 1 | 2023 | 313 | 0.180 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2020 | 66 | 0.180 |
Why?
|
Arginine | 1 | 2023 | 934 | 0.170 |
Why?
|
Pneumonectomy | 2 | 2023 | 1111 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2299 | 0.170 |
Why?
|
Benzylamines | 1 | 2020 | 248 | 0.160 |
Why?
|
Gene Products, nef | 1 | 2019 | 100 | 0.160 |
Why?
|
Heterocyclic Compounds | 1 | 2020 | 247 | 0.160 |
Why?
|
Trachea | 2 | 2015 | 1082 | 0.150 |
Why?
|
Mice, SCID | 2 | 2014 | 2627 | 0.150 |
Why?
|
Stomatitis, Aphthous | 1 | 2018 | 52 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1131 | 0.150 |
Why?
|
Bleomycin | 1 | 2019 | 495 | 0.150 |
Why?
|
Bacterial Toxins | 1 | 2023 | 931 | 0.150 |
Why?
|
Cells, Cultured | 10 | 2019 | 18957 | 0.150 |
Why?
|
Recombinant Proteins | 4 | 2023 | 6538 | 0.150 |
Why?
|
Disease Models, Animal | 4 | 2023 | 18137 | 0.140 |
Why?
|
Paracrine Communication | 1 | 2019 | 277 | 0.140 |
Why?
|
Vasoconstriction | 1 | 2020 | 593 | 0.140 |
Why?
|
Interferon-alpha | 1 | 2021 | 918 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 2 | 2014 | 72 | 0.140 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 2017 | 99 | 0.140 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2018 | 103 | 0.140 |
Why?
|
Proteoglycans | 1 | 2020 | 801 | 0.140 |
Why?
|
Microvessels | 3 | 2017 | 572 | 0.140 |
Why?
|
Cell Hypoxia | 1 | 2019 | 658 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 707 | 0.130 |
Why?
|
Heparin | 1 | 2023 | 1652 | 0.130 |
Why?
|
Muscle Contraction | 1 | 2021 | 1201 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4319 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 2 | 2019 | 2471 | 0.130 |
Why?
|
Signal Transduction | 7 | 2023 | 23376 | 0.130 |
Why?
|
Receptors, CXCR4 | 1 | 2020 | 728 | 0.130 |
Why?
|
Elafin | 1 | 2015 | 31 | 0.120 |
Why?
|
Methamphetamine | 1 | 2017 | 162 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2414 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 2018 | 743 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1959 | 0.120 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 506 | 0.120 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2015 | 112 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2016 | 256 | 0.120 |
Why?
|
Neovascularization, Physiologic | 3 | 2016 | 1336 | 0.120 |
Why?
|
Humans | 30 | 2024 | 760621 | 0.120 |
Why?
|
Antigens | 1 | 2020 | 1447 | 0.120 |
Why?
|
Frizzled Receptors | 1 | 2014 | 90 | 0.120 |
Why?
|
Exosomes | 1 | 2019 | 424 | 0.120 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2014 | 187 | 0.110 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2016 | 410 | 0.110 |
Why?
|
Sulfonamides | 1 | 2023 | 1977 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2019 | 1175 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2020 | 9530 | 0.110 |
Why?
|
3' Untranslated Regions | 2 | 2013 | 514 | 0.110 |
Why?
|
Hydrogels | 1 | 2019 | 723 | 0.110 |
Why?
|
Atherosclerosis | 2 | 2023 | 3517 | 0.110 |
Why?
|
Integrin alpha3 | 1 | 2012 | 26 | 0.110 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 176 | 0.110 |
Why?
|
Microcirculation | 2 | 2015 | 1278 | 0.110 |
Why?
|
PPAR gamma | 1 | 2016 | 484 | 0.110 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1846 | 0.100 |
Why?
|
Leukotrienes | 1 | 2014 | 231 | 0.100 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 1 | 2013 | 158 | 0.100 |
Why?
|
Cell Division | 1 | 2020 | 4463 | 0.100 |
Why?
|
Cyclosporine | 1 | 2015 | 777 | 0.100 |
Why?
|
Cell Transdifferentiation | 1 | 2013 | 185 | 0.100 |
Why?
|
Aspergillus fumigatus | 1 | 2013 | 156 | 0.100 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2012 | 153 | 0.100 |
Why?
|
Blotting, Western | 2 | 2016 | 5039 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 307 | 0.100 |
Why?
|
Magnetics | 1 | 2014 | 600 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2018 | 977 | 0.100 |
Why?
|
Cell Lineage | 1 | 2020 | 2533 | 0.090 |
Why?
|
Mice, Inbred C57BL | 6 | 2023 | 22023 | 0.090 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2012 | 218 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1754 | 0.090 |
Why?
|
Drug Design | 1 | 2016 | 1061 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 621 | 0.080 |
Why?
|
Muscle Proteins | 1 | 2014 | 1152 | 0.080 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1664 | 0.080 |
Why?
|
Drug Discovery | 1 | 2016 | 1057 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2016 | 3775 | 0.070 |
Why?
|
Osteoblasts | 1 | 2013 | 1142 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1613 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11481 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1245 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 6068 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7343 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2012 | 1115 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14372 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2016 | 4490 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3442 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2418 | 0.060 |
Why?
|
Chronic Disease | 1 | 2020 | 9287 | 0.060 |
Why?
|
Rats | 2 | 2019 | 23711 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12766 | 0.060 |
Why?
|
DNA Repair | 1 | 2014 | 2039 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12103 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1150 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11903 | 0.060 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2061 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2019 | 22053 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9467 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2934 | 0.060 |
Why?
|
Apoptosis | 3 | 2017 | 9501 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2448 | 0.050 |
Why?
|
Cell Proliferation | 3 | 2016 | 10446 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2023 | 26181 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 75 | 0.050 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2023 | 132 | 0.050 |
Why?
|
Cecum | 1 | 2023 | 232 | 0.050 |
Why?
|
Hirudins | 1 | 2023 | 194 | 0.050 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4541 | 0.050 |
Why?
|
Substance P | 1 | 2023 | 333 | 0.050 |
Why?
|
Trans-Activators | 1 | 2012 | 2860 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 192 | 0.050 |
Why?
|
Endothelium, Vascular | 4 | 2016 | 4433 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2015 | 2884 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4426 | 0.050 |
Why?
|
Thrombin | 1 | 2023 | 593 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 370 | 0.050 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2023 | 314 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10756 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 4938 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2016 | 1529 | 0.040 |
Why?
|
Adolescent | 3 | 2019 | 87810 | 0.040 |
Why?
|
Middle Aged | 6 | 2019 | 220352 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9411 | 0.040 |
Why?
|
Female | 11 | 2019 | 391270 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5791 | 0.040 |
Why?
|
Adult | 5 | 2019 | 219994 | 0.040 |
Why?
|
Male | 9 | 2019 | 359744 | 0.040 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 148 | 0.040 |
Why?
|
Child | 2 | 2019 | 79806 | 0.040 |
Why?
|
Pluripotent Stem Cells | 1 | 2024 | 792 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2015 | 3094 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1436 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 869 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1726 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9585 | 0.030 |
Why?
|
Clostridium Infections | 1 | 2023 | 557 | 0.030 |
Why?
|
E2F1 Transcription Factor | 1 | 2016 | 178 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 2019 | 482 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 16939 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6216 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2023 | 1881 | 0.030 |
Why?
|
Anticoagulants | 2 | 2023 | 4897 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2016 | 435 | 0.030 |
Why?
|
Leukocyte Elastase | 1 | 2015 | 114 | 0.030 |
Why?
|
Phosphorylation | 2 | 2016 | 8313 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 256 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2023 | 2167 | 0.030 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2014 | 128 | 0.030 |
Why?
|
Glycerophosphates | 1 | 2013 | 47 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 256 | 0.030 |
Why?
|
Complement C3 | 1 | 2015 | 451 | 0.030 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2015 | 590 | 0.030 |
Why?
|
Osteocalcin | 1 | 2013 | 274 | 0.030 |
Why?
|
Mutation | 2 | 2014 | 29932 | 0.030 |
Why?
|
COS Cells | 1 | 2014 | 1129 | 0.030 |
Why?
|
Gene Expression | 2 | 2016 | 7588 | 0.030 |
Why?
|
Chemotaxis | 1 | 2015 | 598 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3804 | 0.020 |
Why?
|
HIV | 1 | 2019 | 1579 | 0.020 |
Why?
|
Aspergillosis | 1 | 2013 | 243 | 0.020 |
Why?
|
Protease Inhibitors | 1 | 2015 | 755 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2023 | 5125 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1347 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2013 | 459 | 0.020 |
Why?
|
Perfusion | 1 | 2015 | 1376 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1737 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1490 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1173 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1755 | 0.020 |
Why?
|
Neoplasms | 1 | 2018 | 22072 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2012 | 441 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1337 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1500 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2222 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2016 | 2693 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2014 | 1147 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2846 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2913 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1513 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8482 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2566 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11071 | 0.020 |
Why?
|
Swine | 1 | 2015 | 5899 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 1447 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6498 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 7806 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5785 | 0.010 |
Why?
|
Graft Survival | 1 | 2015 | 3794 | 0.010 |
Why?
|
DNA Damage | 1 | 2014 | 2442 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 1999 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6965 | 0.010 |
Why?
|
Aged | 2 | 2018 | 169152 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2788 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12531 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3106 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4713 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2879 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8035 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5797 | 0.010 |
Why?
|
Chromatin | 1 | 2014 | 2938 | 0.010 |
Why?
|
Genetic Testing | 1 | 2014 | 3531 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14660 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5643 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15289 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10181 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13502 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24123 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17790 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 58741 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74359 | 0.010 |
Why?
|